GQ-16, a Novel Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand, Promotes Insulin Sensitization without Weight Gain

Background: PPARγ agonists improve insulin sensitivity but also evoke weight gain.

Bibliographic Details
Main Authors: Amato, Angélica A., Rajagopalan, Senapathy, Lin, Jean Z., Carvalho, Bruno M., Figueira, Ana C. M., Lu, Jenny, Ayers, Stephen D., Mottin, Melina, Silveira, Rodrigo L., Souza, Paulo C. T., Mourão, Rosa H. V., Saad, Mário J. A., Togashi, Marie, Simeoni, Luiz A., Abdalla, Dulcinéia S. P., Skaf, Munir S., Polikparpov, Igor, Lima, Maria C. A., Galdino, Suely L., Brennan, Richard G., Baxter, John D., Pitta, Ivan R., Webb, Paul, Phillips, Kevin J., Neves, Francisco A. R.
Format: Online
Language:English
Published: American Society for Biochemistry and Molecular Biology 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431672/
Description
Summary:Background: PPARγ agonists improve insulin sensitivity but also evoke weight gain.